Effects of perioperative parenteral glutamine-dipeptide supplementation on plasma endotoxin level, plasma endotoxin inactivation capacity and clinical outcome

Clinical Nutrition

Volumn 24, Issue 4, 2005, Pages 510-515

  Yao, Guo Xiang ^a   Xue, Xin Bo ^a   Jiang, Zhu Ming ^b   Yang, Nai Fa ^b   Wilmore, Douglas W ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endotoxin; Endotoxin inactivation capacity; Glutamine

Indexed keywords

ALANYLGLUTAMINE; CEFTRIAXONE; ENDOTOXIN; IMMUNOSUPPRESSIVE AGENT; SOLUBLE CD4 ANTIGEN;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INFUSION; ENDOTOXEMIA; GASTROINTESTINAL SURGERY; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; LENGTH OF STAY; PARENTERAL NUTRITION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, CD14; DIETARY SUPPLEMENTS; DIPEPTIDES; DOUBLE-BLIND METHOD; ENDOTOXINS; FEMALE; GASTROINTESTINAL TRACT; GLUTAMINE; HUMANS; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PERIOPERATIVE CARE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 22944480862     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2005.04.002     Document Type: Article

References (20)

1. D.W. Wilmore R.J. Smith S.T. O'Dwyer D.O. Jacobs T.R. Ziegler X.D. Wang The gut: A central organ after surgical stress Surgery 104 1988 917-923
2. M.K. Angele E. Faist Clinical review: Immunodepression in the surgical patient and increased susceptibility to infection Crit Care 6 2002 298-305
3. E.S.V. Amersfoort T.J.C. Van Berkel J. Kuiper Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock Clin Microbiol Rev 16 2003 379-414
4. H.S. Warren T.J. Novitsky P.A. Ketchum P.F. Roslansky S. Kania G.R. Siber Neutralization of bacterial lipopolysaccharides by human plasma J Clin Microbiol 22 1985 590-595
5. D. Berger S. Schleich M. Seidelmann et al. Correlation between endotoxin-neutralizing capacity of human plasma as tested by the limulus-amebocyte-lysate-test and plasma protein levels FEBS 277 1990 33-36
6. J. Cohen J.S. MaConnell Observation on the measurement and evaluation of endotoxemia by a quantitative Limulus lysate microassay J Infect Dis 150 1984 916-924
7. K. Buttenschoen D.C. Buttenschoen D. Berger et al. Endotoxemia and acute-phase proteins in major abdominal surgery Am J Surg 181 2001 36-43
8. N. Hiki D. Berger Y. Mimura et al. Release of endotoxin-binding proteins during major elective surgery: Role of soluble CD14 in phagocytic activation World J Surg 24 2000 499-506
9. D. Muckart S. Bhagwanjee American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions the systemic inflammatory response syndrome and allied disorders in relation to ciritically injured patients Crit Clin Med 25 1997 1789-1795
10. J. MacFie C. McNaught Glutamine and gut barrier function Nutrition 18 2002 433-434
11. Z.M. Jiang J.D. Cao X.G. Zhu et al. The impact of alanyl-glutamine on clinical safety nitrogen balance, intestinal permeability and clinical outcome in posoperative patients randomized, double-blind, controlled study of l20 patients J Parenter Enteral Nutr 23 1999 S62-S66
12. Y. Tazuke M. Wasa Y. Shimizu H.S. Wang A. Okada Alanyl-glutamine-supplemented parenteral nutrition prevents intestinal ischemia-reperfusion injury in rats J Parenter Enteral Nutr 27 2003 110-115
13. H.J. Kirk S.D. Heys Immunonutrition Br J Surg 90 2003 1459-1460
14. G.C. Melis N. ter Wengel P.G. Boelens P.A. van Leeuwen Glutamine: Recent developments in research on the clinical significance of glutamine Curr Opin Clin Nutr Metab Care 7 2004 59-70
15. R.L. Kitchens P.A. Thompson Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: Roles of soluble CD14, LBP, and acute phase lipoproteins J Endotoxin Res 9 2003 113-118
16. S.H. Rahman G. Salter J.H. Holmfield M. Larvin M.J. McMahon Soluble CD14 receptor expression and monocyte heterogeneity but not the C-260 T CD14 genotype are associated with severe acute pancreatitis Crit Care Med 32 2004 2457-2463
17. F. Novak D.K. Heyland A. Avenell J.W. Drover X. Su Glutamine supplementation in serious illness: A systematic review of the evidence Crit Care Med 30 2002 2022-2029
18. M.T. Lin S.P. Kung S.L. Yeh et al. The effect of glutamine-supplemented total parenteral nutrition on nitrogen economy depends on severity of diseases in surgical patients Clin Nutr 21 2002 213-218
19. A. Dhar S. Kujath C.W. Van-Way Glutamine administration during total parenteral nutrition protects liver adenosine nucleotides during and after subsequent hemorrhagic shock J Parenter Enteral Nutr 27 2003 246-251
20. C. Fuentes Orozco R. Anaya Prado A. Gonzalez Ojeda et al. l-alanyl-l-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis Clin Nutr 23 2004 13-21